119 related articles for article (PubMed ID: 38154548)
21. Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway.
Won SH; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Jung DB; Shin JM; Kwon TR; Yun SM; Lee MH; Choi SH; Lü J; Kim SH
Biol Pharm Bull; 2010; 33(11):1828-34. PubMed ID: 21048307
[TBL] [Abstract][Full Text] [Related]
22. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
[TBL] [Abstract][Full Text] [Related]
23. Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways.
Lim W; Park S; Bazer FW; Song G
J Cell Biochem; 2017 May; 118(5):1118-1131. PubMed ID: 27606834
[TBL] [Abstract][Full Text] [Related]
24. Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.
Steely AM; Willoughby JA; Sundar SN; Aivaliotis VI; Firestone GL
Anticancer Drugs; 2017 Oct; 28(9):1018-1031. PubMed ID: 28708672
[TBL] [Abstract][Full Text] [Related]
25. Tumor-suppressive activity of 1,25-dihydroxyvitamin D3 against kidney cancer cells via up-regulation of FOXO3.
Lee J; Park SH
Biosci Biotechnol Biochem; 2016 Oct; 80(10):1947-53. PubMed ID: 27181027
[TBL] [Abstract][Full Text] [Related]
26. The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim.
Nikrad M; Johnson T; Puthalalath H; Coultas L; Adams J; Kraft AS
Mol Cancer Ther; 2005 Mar; 4(3):443-9. PubMed ID: 15767553
[TBL] [Abstract][Full Text] [Related]
27. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression.
Li B; Dou QP
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):3850-5. PubMed ID: 10725400
[TBL] [Abstract][Full Text] [Related]
28. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J
Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834
[TBL] [Abstract][Full Text] [Related]
29. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
[TBL] [Abstract][Full Text] [Related]
30. Corn silk maysin induces apoptotic cell death in PC-3 prostate cancer cells via mitochondria-dependent pathway.
Lee J; Lee S; Kim SL; Choi JW; Seo JY; Choi DJ; Park YI
Life Sci; 2014 Dec; 119(1-2):47-55. PubMed ID: 25445226
[TBL] [Abstract][Full Text] [Related]
31. Mycotoxin verrucarin A inhibits proliferation and induces apoptosis in prostate cancer cells by inhibiting prosurvival Akt/NF-kB/mTOR signaling.
Liu Y; Gao X; Deeb D; Zhang Y; Shaw J; Valeriote FA; Gautam SC
J Exp Ther Oncol; 2016 Nov; 11(4):251-260. PubMed ID: 27849335
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine.
Zhang YX; Liu XM; Wang J; Li J; Liu Y; Zhang H; Yu XW; Wei N
Cancer Biol Ther; 2015; 16(6):965-75. PubMed ID: 25893985
[TBL] [Abstract][Full Text] [Related]
33. Biological activities of sinularin: A literature-based review.
Islam MT; Hossain R; Hassan SMH; Salehi B; Martins N; Sharifi-Rad J; Amarowicz R
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(4):33-36. PubMed ID: 32583788
[TBL] [Abstract][Full Text] [Related]
34. S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.
Lu Z; Zhou R; Kong Y; Wang J; Xia W; Guo J; Liu J; Sun H; Liu K; Yang J; Mi M; Xu H
Curr Cancer Drug Targets; 2016; 16(5):455-65. PubMed ID: 26638886
[TBL] [Abstract][Full Text] [Related]
35. Sinularin from indigenous soft coral attenuates nociceptive responses and spinal neuroinflammation in carrageenan-induced inflammatory rat model.
Huang SY; Chen NF; Chen WF; Hung HC; Lee HP; Lin YY; Wang HM; Sung PJ; Sheu JH; Wen ZH
Mar Drugs; 2012 Sep; 10(9):1899-1919. PubMed ID: 23118711
[TBL] [Abstract][Full Text] [Related]
36. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity.
Du WW; Fang L; Yang W; Wu N; Awan FM; Yang Z; Yang BB
Cell Death Differ; 2017 Feb; 24(2):357-370. PubMed ID: 27886165
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of the forkhead transcription factor FoxO3 is essential for PKB-mediated survival of hematopoietic progenitor cells by kit ligand.
Engström M; Karlsson R; Jönsson JI
Exp Hematol; 2003 Apr; 31(4):316-23. PubMed ID: 12691919
[TBL] [Abstract][Full Text] [Related]
38. Eriocalyxin B Induces Apoptosis and Autophagy Involving Akt/Mammalian Target of Rapamycin (mTOR) Pathway in Prostate Cancer Cells.
Yu Z; Chen Y; Liang C
Med Sci Monit; 2019 Nov; 25():8534-8543. PubMed ID: 31714902
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of MUC4 potentiates the anticancer activity of auranofin via regulation of the Her2/Akt/FOXO3 pathway in ovarian cancer cells.
Bae JS; Lee J; Park Y; Park K; Kim JR; Cho DH; Jang KY; Park SH
Oncol Rep; 2017 Oct; 38(4):2417-2425. PubMed ID: 28765909
[TBL] [Abstract][Full Text] [Related]
40. Two-step activation of FOXO3 by AMPK generates a coherent feed-forward loop determining excitotoxic cell fate.
Davila D; Connolly NM; Bonner H; Weisová P; Dussmann H; Concannon CG; Huber HJ; Prehn JH
Cell Death Differ; 2012 Oct; 19(10):1677-88. PubMed ID: 22539004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]